Masuhiro Nishimura
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 32
- Drug Transport and Resistance Mechanisms 28
- Pharmacology 28
- Pharmacogenetics and Drug Metabolism 27
- Drug-Induced Hepatotoxicity and Protection 8
- Co-authors
- Shinsaku Naito (54 shared papers)Tetsuo Satoh (10 shared papers)H. Yoshitsugu (5 shared papers)Tsuyoshi Yokoi (6 shared papers)Nobuhiko Ueda (13 shared papers)Aiko Yamauchi (12 shared papers)Shizuo Narimatsu (12 shared papers)Mitsuo Nakayama (7 shared papers)
In The Last Decade
Masuhiro Nishimura
88 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 836
- Oncology 943
- Biochemistry 204
- Hepatology 184
- Clinical Biochemistry 134
Countries citing papers authored by Masuhiro Nishimura
This map shows the geographic impact of Masuhiro Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masuhiro Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masuhiro Nishimura more than expected).
Fields of papers citing papers by Masuhiro Nishimura
This network shows the impact of papers produced by Masuhiro Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masuhiro Nishimura. The network helps show where Masuhiro Nishimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Masuhiro Nishimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 385 | |
| 2 | 2005 | 305 | |
| 3 | 2003 | 265 | |
| 4 | 2006 | 186 | |
| 5 | 2009 | 182 | |
| 6 | 2008 | 158 | |
| 7 | 2004 | 157 | |
| 8 | 1986 | 130 | |
| 9 | 2005 | 92 | |
| 10 | 2002 | 75 | |
| 11 | 2004 | 73 | |
| 12 | 2007 | 59 | |
| 13 | 1996 | 58 | |
| 14 | 2005 | 58 | |
| 15 | 2003 | 56 | |
| 16 | 2005 | 53 | |
| 17 | 2009 | 47 | |
| 18 | 2004 | 42 | |
| 19 | 2005 | 40 | |
| 20 | Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells. | 2005 | 40 |
About Masuhiro Nishimura
Masuhiro Nishimura is a scholar working on Oncology, Pharmacology, Molecular Biology, Surgery and Genetics, having authored 91 papers that have together received 3.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (28 papers), Pharmacogenetics and Drug Metabolism (27 papers), Metabolism and Genetic Disorders (11 papers), Mesenchymal stem cell research (9 papers), Gout, Hyperuricemia, Uric Acid (8 papers), Pancreatic function and diabetes (8 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Pharmacology (836 citations), Oncology (943 citations), Biochemistry (204 citations), Hepatology (184 citations) and Clinical Biochemistry (134 citations). Masuhiro Nishimura has collaborated with scholars based in Japan, Spain and Egypt. Frequent co-authors include Shinsaku Naito, Tetsuo Satoh, H. Yoshitsugu, Tsuyoshi Yokoi, Nobuhiko Ueda, Aiko Yamauchi, Shizuo Narimatsu, Mitsuo Nakayama, Chise Tateno and Katsutoshi Yoshizato. Their work appears in journals such as Drug Metabolism and Pharmacokinetics, Biological and Pharmaceutical Bulletin, Xenotransplantation, The Journal of Biochemistry and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.